Breakthrough findings demonstrate a possible target and potential drug treatment to restore memory loss and extend life span in mice with neurodegeneration
“We have treated mice with a new type of drug, and found that these drugs can not only improve symptoms of brain degeneration, such as cognitive decline, but can also extend the life-span of these terminally-sick mice. Our study opens up avenues for researchers to look at new drugs that treat the symptoms of Alzheimer’s and also slow disease progression”
– Professor Andrew Tobin
An international team of scientists has announced a new advance in the fight against Alzheimer’s disease by identifying a new drug target for not only improving symptoms of brain degeneration – but also to extend the life-span of the terminally ill mice.
The four-year study by Medical Research Council (MRC) scientists based at the MRC Toxicology Unit at the University of Leicester is published in the Journal of Clinical Investigation. The study was led by Professor Andrew Tobin alongside colleagues from pharmaceutical company Eli Lilly and Company and the Monash Institute for Pharmaceutical Sciences in Australia. The project was also partly supported by the Wellcome Trust.
Corresponding author Professor Tobin, who alongside the lead researcher Dr Sophie Bradley has since moved from the University of Leicester to the University of Glasgow, said: “The paper describes drug-like molecules that can restore memory loss and slow progression of prion neurodegenerative disease in a manner that relates to the potential of these drugs in human Alzheimer’s disease.
“We have been using mice whose brain cells are progressively dying, similar to what happens in Alzheimer’s disease. This project focuses on a particular protein in the brain, which is proposed to be involved in Alzheimer’s disease, and as such could be a potential target for new drugs.
“We have treated mice with a new class of drug, and found that these drugs can not only improve symptoms of brain degeneration, such as cognitive decline, but can also extend the life-span of these terminally-sick mice.”
The researchers state that drugs which activate this protein receptor in the brain have previously been tested in clinical trials for Alzheimer’s disease, and showed positive results with respect to improving cognition, but the patients experienced a large number of adverse side effects. This new class of drug is more selective and does not cause any side-effects when administered to mice in the study.
The study authors believe that this offers hope in the design of new drugs for improving cognition and extending life span.
Professor Tobin said: “This work may provide important information as to whether this protein is a viable drug target in the treatment of diseases associated with the progressive death of brain cells. This is of great importance to society, based on the fact that the treatment options for Alzheimer’s disease are very limited – there are no cures for Alzheimer’s disease and current treatments are focused on relieving some of the symptoms.
“What we have found is a novel class of drugs, called allosteric ligands, that target a protein called the M1 muscarinic receptor, which is present in the brain. Activating this receptor protein can not only improve cognitive function in mice with progressive brain degeneration, but when administered daily, can extend life span.”
The scientists say the work is important because it focuses on identifying a treatment that not only improves symptoms associated with neurodegeneration, like current treatments, but also identifies a new strategy for slowing disease progression and extending life-span.
Professor Tobin said: “Alzheimer’s disease is the most common form of dementia, and it affects an estimated 850,000 people in the UK alone. There are no treatments that can slow or halt the progression of Alzheimer’s, and patients are treated with drugs which temporarily mask the symptoms of the disease. Often these treatments are associated with side-effects which can limit patient compliance.
“I am proud to be involved in a collaboration with researchers across the world to address one of the world’s major healthcare challenges. Our study opens up avenues for researchers to look at new drugs that treat the symptoms of Alzheimer’s and also slow disease progression.”
Receive an email update when we add a new ALZHEIMERS article.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- Veteran with Alzheimers reportedly scammed out of $4,000 from flood repair contractor on December 19, 2018 at 2:47 pm
MYRTLE BEACH, SC - The Rosewood neighborhood in Socastee is one of many areas in Horry County still piecing their lives back together from Hurricane Florence. In the midst of recovery, some residents ... […]
- Missing pensioner with Alzheimers last seen in Birmingham on December 18, 2018 at 10:29 am
Police are growing increasing concerned for the safety of a woman who suffers from Alzheimers who may be lost in Birmingham. Police have released this image of the woman in a bid to try and find her T... […]
- Your old iPods can spark music memories for Fifers with alzheimers on December 14, 2018 at 2:53 am
The power of music to unlock memories in those experiencing the advance of Alzheimers is the basis for an innovative approach to patient care being introduced across the NHS in Fife. Already bringing ... […]
- Senate passes Alzheimers legislation on December 13, 2018 at 11:18 am
After unanimous passage the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act in the U.S. Senate, the legislation now goes to the House of Representatives for consideration. The ... […]
- Little Falls police complete new Alzheimer's awareness training on December 9, 2018 at 4:19 am
Police interaction with individuals who suffer from Alzheimer's disease is not limited to when they become confused and lost. A person's chances of interaction with police increase with a dementia dia... […]
- Q-Tip Reveals That He’s a Caregiver for His Mother Who Suffers From Alzheimers and Dementia on December 5, 2018 at 8:11 am
Q-Tip is pretty low-key about his personal life but he recently gave us a little insight into his day-to-day life on Instagram. Tip has his own Beats 1 Radio called Abstract Radio and announced that h... […]
- Giving Tuesday: Support Programs at Alzheimers Coachella Valley on November 27, 2018 at 8:26 am
This post was contributed by a community member. Today is Giving Tuesday! Thanks for continued community support, Alzheimers Coachella Valley (ACV) has been able to serve more than 1,000 Coachella Val... […]
- Rememberly — A UX case study to help people affected by Alzheimer’s and Dementia on November 15, 2018 at 9:04 pm
I had the opportunity to collaborate with Sara Hathoway, Sean Rockwood, and Uliti Fangupo to design a web based solution helping people who suffer from Alzheimers or Dementia. The goal was to create a ... […]
- Heritage Park sees hundreds for Alzheimers walk on September 23, 2018 at 5:37 pm
Hundreds of locals filled St. Joseph’s Heritage Park Sunday morning to take part in an awareness walk for one of the country’s leading diseases. The third annual Walk to End Alzheimer’s is one event o... […]
via Bing News